(Q46915319)

26 December 2017

title

Sirolimus in de novo heart transplant recipients with severe renal impairment (English)

1 reference

26 December 2017

1 reference

Jose A Vazquez de Prada

1

1 reference

26 December 2017

Francisco G Vilchez

2

1 reference

26 December 2017

Manuel Cobo

3

1 reference

26 December 2017

Cristina Ruisanchez

4

1 reference

26 December 2017

Mónica F Valls

5

1 reference

26 December 2017

Javier Ruano

6

1 reference

26 December 2017

Celestino Piñera

7

1 reference

26 December 2017

Rafael M Duran

8

1 reference

26 December 2017

publication date

1 March 2006

1 reference

26 December 2017

published in

Transplant International

1 reference

26 December 2017

volume

19

1 reference

26 December 2017

issue

3

1 reference

26 December 2017

page(s)

245-248

1 reference

26 December 2017

The clinical challenge of cardiorenal syndrome

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00258.X

Maximizing the clinical outcome with mTOR inhibitors in the renal transplant recipient: defining the role of calcineurin inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00258.X

Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00258.X

Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00258.X

De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00258.X

A retrospective review of liver transplant patients treated with sirolimus from a single center: an analysis of sirolimus-related complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00258.X

Sirolimus allows renal recovery in lung and heart transplant recipients with chronic renal impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00258.X

Mycophenolate mofetil and sirolimus as calcineurin inhibitor-free immunosuppression for late cardiac-transplant recipients with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00258.X

Sirolimus improves renal function in cardiac transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00258.X

Initial experience with sirolimus and mycophenolate mofetil for renal rescue from cyclosporine nephrotoxicity after heart transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00258.X

Sirolimus immunosuppression in pediatric heart transplant recipients: a single-center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00258.X

Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00258.X

Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00258.X

First experience with de novo calcineurin-inhibitor-free immunosuppression following cardiac transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00258.X

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00258.X

10.1111/J.1432-2277.2005.00258.X

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017